OSE Immunotherapeutics and Oncology Physician Network GERCOR Announce Submission of a Clinical Trial Application to Evaluate Tedopi® in Combination with Nivolumab in Pancreatic Cancer

The Phase 2 clinical trial of Tedopi® in pancreatic cancer will be sponsored by the oncology group GERCOR…